印度公司 Zydus Lifesciences 获得美国 FDA 批准生产仿制地塞米松片剂。 Indian firm Zydus Lifesciences receives US FDA approval for generic dexamethasone tablets.

印度制药公司 Zydus Lifesciences 获得美国 FDA 批准，可生产用于治疗关节炎、过敏和癌症的仿制地塞米松片剂。 Indian pharmaceutical firm Zydus Lifesciences receives US FDA approval for generic dexamethasone tablets, used to treat arthritis, allergies, and cancer. 此前，该公司的氨苯砜凝胶已获批准用于治疗痤疮。 This follows the approval for its Dapsone Gel for acne treatment. 这些药片将在该公司位于喜马偕尔邦巴迪的工厂生产。 The tablets will be manufactured at the company's facility in Baddi, Himachal Pradesh. Zydus 自 2003-04 财年成立以来，已获得 395 项批准并提交了超过 460 份简化新药申请。 Zydus has 395 approvals and has filed over 460 Abbreviated New Drug Applications since its commencement in FY 2003-04.